Homo sapiens Protein: DLAT | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||
InnateDB Protein | IDBP-71183.6 | ||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||
Gene Symbol | DLAT | ||||||||||||||||||||||
Protein Name | dihydrolipoamide S-acetyltransferase | ||||||||||||||||||||||
Synonyms | DLTA; PDC-E2; PDCE2; | ||||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||||
Ensembl Protein | ENSP00000280346 | ||||||||||||||||||||||
InnateDB Gene | IDBG-71181 (DLAT) | ||||||||||||||||||||||
Protein Structure |
![]() |
||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||
Function | The pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), and thereby links the glycolytic pathway to the tricarboxylic cycle. | ||||||||||||||||||||||
Subcellular Localization | Mitochondrion matrix. | ||||||||||||||||||||||
Disease Associations | Note=Primary biliary cirrhosis is a chronic, progressive cholestatic liver disease characterized by the presence of antimitochondrial autoantibodies in patients' serum. It manifests with inflammatory obliteration of intra-hepatic bile duct, leading to liver cell damage and cirrhosis. Patients with primary biliary cirrhosis show autoantibodies against the E2 component of pyruvate dehydrogenase complex.Pyruvate dehydrogenase E2 deficiency (PDHE2 deficiency) [MIM:245348]: Pyruvate dehydrogenase (PDH) deficiency is a major cause of primary lactic acidosis and neurological dysfunction in infancy and early childhood. In this form of PDH deficiency episodic dystonia is the major neurological manifestation, with other more common features of pyruvate dehydrogenase deficiency, such as hypotonia and ataxia, being less prominent. {ECO:0000269PubMed:16049940}. Note=The disease is caused by mutations affecting the gene represented in this entry. | ||||||||||||||||||||||
Tissue Specificity | |||||||||||||||||||||||
Comments | |||||||||||||||||||||||
Interactions | |||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 28 experimentally validated interaction(s) in this database.
They are also associated with 2 interaction(s) predicted by orthology.
|
||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||
PDB ID | |||||||||||||||||||||||
InterPro |
IPR000089
Biotin/lipoyl attachment IPR001078 2-oxoacid dehydrogenase acyltransferase, catalytic domain IPR004167 E3 binding IPR006257 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex IPR011053 Single hybrid motif |
||||||||||||||||||||||
PFAM |
PF00364
PF00198 PF02817 |
||||||||||||||||||||||
PRINTS | |||||||||||||||||||||||
PIRSF | |||||||||||||||||||||||
SMART | |||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||
Modification | |||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||
SwissProt | P10515 | ||||||||||||||||||||||
PhosphoSite | PhosphoSite-P10515 | ||||||||||||||||||||||
TrEMBL | Q86YI5 | ||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||
Entrez Gene | 1737 | ||||||||||||||||||||||
UniGene | Hs.645882 | ||||||||||||||||||||||
RefSeq | NP_001922 | ||||||||||||||||||||||
HUGO | HGNC:2896 | ||||||||||||||||||||||
OMIM | 608770 | ||||||||||||||||||||||
CCDS | CCDS8354 | ||||||||||||||||||||||
HPRD | 10578 | ||||||||||||||||||||||
IMGT | |||||||||||||||||||||||
EMBL | AK057299 AK223596 AP000907 BC039084 EF444972 J03866 Y00978 | ||||||||||||||||||||||
GenPept | AAA62253 AAH39084 ACA05975 BAD97316 BAG51900 CAA68787 | ||||||||||||||||||||||